Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis. | J Invest Dermatol;129(9): 2299-302, 2009 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.

Boy, Mary G; Wang, Cunshan; Wilkinson, Bethanie E; Chow, Vincent Fung-Sing; Clucas, Alan T; Krueger, James G; Gaweco, Anderson S; Zwillich, Samuel H; Changelian, Paul S; Chan, Gary.

J Invest Dermatol ; 129(9): 2299-302, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19225543

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pyrimidines / Pyrroles Type of study: Clinical_trials Limits: Adult / Humans / Middle aged Language: En Journal: J Invest Dermatol Year: 2009 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pyrimidines / Pyrroles Type of study: Clinical_trials Limits: Adult / Humans / Middle aged Language: En Journal: J Invest Dermatol Year: 2009 Document type: Article